THEMIS MEDICARE
|
The Current P/E Ratio of THEMIS MEDICARE is 43.72.
Share Price | ₹165.1 | Feb 18,2025 |
Market Cap | ₹1,518.5 Cr | |
Earnings-TTM | ₹34.7 Cr | TTM-Consolidated Results |
Price/Earnings | 43.72x | Calculated as Market Cap/Earnings |
---|---|---|
Explore Stock Analytics |
Definition & Calculation of PE (Price/Earnings) ratio of THEMIS MEDICARE
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹1,518.5 Cr] as on Feb 18,2025
(/) Earnings [ ₹34.7 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 43.72x ]
Thus, for THEMIS MEDICARE , the investors are currently willing to pay 43.72 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of THEMIS MEDICARE !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of THEMIS MEDICARE over the last five years.
Historical PE (Price/Earnings) ratio chart of THEMIS MEDICARE
PE Ratio Performance Analysis for THEMIS MEDICARE
- THEMIS MEDICARE 's p/e ratio for fiscal years ending Mar2024 to Mar2020 averaged 13.10x.
- THEMIS MEDICARE 's operated at median p/e ratio of 7.21x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, THEMIS MEDICARE 's p/e ratio peaked in Mar2024 at 46.31x.
- THEMIS MEDICARE 's p/e ratio hit its five-year low in Mar2022 of 1.18x.
How does THEMIS MEDICARE 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
---|---|---|---|
THEMIS MEDICARE | 34.73 | 43.72 | 1,518.5 |
SUN PHARMACEUTICAL INDUSTRIES LTD | 11,486.00 | 35.54 | 408,259.0 |
CIPLA LTD | 5,000.43 | 23.94 | 119,705.0 |
DR REDDYS LABORATORIES LTD | 5,428.60 | 18.41 | 99,953.9 |
ZYDUS LIFESCIENCES LTD | 4,591.80 | 20.01 | 91,889.3 |
DIVIS LABORATORIES LTD | 2,067.00 | 74.95 | 154,917.0 |
MANKIND PHARMA LTD | 2,050.73 | 48.02 | 98,468.0 |
TORRENT PHARMACEUTICALS LTD | 1,862.00 | 55.37 | 103,101.0 |
LUPIN LTD | 2,892.10 | 31.77 | 91,887.3 |
AUROBINDO PHARMA LTD | 3,500.25 | 19.32 | 67,608.2 |
ABBOTT INDIA LTD | 1,334.46 | 46.68 | 62,299.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs THEMIS MEDICARE 's P/E Ratio
Top 10 Industry Peers | PE Ratio |
---|---|
Min industry PE | 18.41x |
Max industry PE | 74.95x |
Median industry PE | 35.54x |
Average industry PE | 37.98x |
You may also like the below Video Courses